About Phoenix Pharmaceuticals
Phoenix Pharmaceuticals is a company based in Burlingame (United States) founded in 1994 by Eng Tau. It operates as a B2B. Phoenix Pharmaceuticals offers products and services including Research Peptides, Custom Peptide Synthesis, Antibodies, and Assay Kits. Phoenix Pharmaceuticals operates in a competitive market with competitors including PrognomiQ, PreOmics, Vivostat, List Biological Laboratories and LenioBio, among others.
- Headquarter Burlingame, United States
- Founders Eng Tau
- SectorsHealthcare
- Phone•••• ••••
- Website phoenixpeptide.com
- Social Facebook
- Legal Name Phoenix Pharmaceuticals, Inc.
Products & Services of Phoenix Pharmaceuticals
Phoenix Pharmaceuticals offers a comprehensive portfolio of products and services, including Research Peptides, Custom Peptide Synthesis, Antibodies, and Assay Kits.
Synthetic peptides for scientific and research applications.
Tailored peptide creation for specific research needs.
Polyclonal antibodies for detecting proteins in studies.
Kits for measuring peptide and hormone levels.
People of Phoenix Pharmaceuticals
1 people are tracked at Phoenix Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
Eng Tau | Founder | Leadership |
Complete people profiles for Phoenix Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Phoenix Pharmaceuticals
Phoenix Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, Vivostat, List Biological Laboratories and LenioBio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| preomics.com | 2014 | Munich, Germany | $19.14M | 22 | Reagents and instruments for proteomics research are supplied by PreOmics. | |
| vivostat.com | 2001 | Alleroed, Denmark | $12.89M | 9 | On-site fibrin sealant preparation systems are developed and provided. | |
| listlabs.com | 1978 | Campbell, United States | $48.4M | – | Specializes in the production of research reagents | |
| leniobio.com | 2016 | Dusseldorf, Germany | $13.01M | 18 | Kits for cell-free eukaryotic protein expression are provided. | |
| expedeon.com | 2003 | Swavesey, United Kingdom | $390,000 | 1,587 | Reagents and kits for protein-based research are developed and supplied. | |
| mjbiopharm.com | 2002 | Mumbai, India | $9.13M | 265 | Animal and human rDNA Insulin products and dosage forms | |
| acrobiosystems.com | 2016 | Newark, United States | – | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. | |
| anshlabs.com | 2010 | Webster, United States | – | 33 | Immunoassay reagents and kits are developed for life science research. |
Detailed competitors of Phoenix Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phoenix Pharmaceuticals
The website of Phoenix Pharmaceuticals (phoenixpeptide.com) receives about 102.4K visits a month.
- Monthly visits102.4K
▲ 49.4% vs previous month
Websites whose visitors overlap most with Phoenix Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biosynth.com | 100% | 211.7K | #204,110 | View details | |
| anaspec.com | 93% | 30.1K | #1,080,158 | View details | |
| covalab.com | 89% | 5.3K | #3,616,510 | View details | |
| eurogentec.com | 77% | 40.4K | #771,641 | View details | |
| antibodies-online.com | 70% | 57.4K | #648,443 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Phoenix Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Phoenix Pharmaceuticals
10 companies that operate in the same segment as Phoenix Pharmaceuticals (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phoenix Pharmaceuticals
Phoenix Pharmaceuticals was founded in 1994.
Phoenix Pharmaceuticals is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.
Phoenix Pharmaceuticals produces high-quality research peptides, custom synthesis services, antibodies, and assay kits for biomedical applications. The company operates from its facility in Burlingame, California, USA, serving researchers in fields like obesity, cancer, and diabetes. It offers products for academic and pharmaceutical needs, focusing on peptide manufacturing and related tools to advance scientific discovery.
Phoenix Pharmaceuticals offers Research Peptides, Custom Peptide Synthesis, Antibodies, and Assay Kits.
Phoenix Pharmaceuticals operates through Phoenix Pharmaceuticals, Inc..
The website of Phoenix Pharmaceuticals receives about 102 thousand visits a month.